Commentary · 8 Apr 2026
Conference abstractPublished 24 Oct 2016
K+ channel blocker-induced neurodegenerative model: Pharmaco-immunomodulation effect of an antioxidant drug
University of Science and Technology Houari Boumediene, Algeria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Channelopathies due to the brain ion channel dysfunction is considered to be an important mechanism involved in various neurodegenerative diseases such as epilepsy. In this study, a neurodegenerative model was developed using KTX a neuroexcitotoxic agent that blocks specifically Kv1 channels in the CNS, to explore the pathogenesis of excitotoxicity in neurodegenerative disorders. The detection of the KTX was analyzed by immunofluorescence in various brain areas, neuroinflammatory parameters (i.e. levels of NO, MDA, GSH, catalase, proinflammatory cytokines IL-6 and TNFÃ?Â?Ã?±), NF-Ã?Â?Ã?ºB expression and tissue analysis of neurodegenerative alterations were evaluated with or without pretreatment using an antioxidant (astaxantin). Results showed that KTX was detected only in cerebral cortex area after 1 day due to its binding to the specific receptors. It induced an activation of inflammatory cascade characterized by an increase of IL-6, TNFÃ?Â?Ã?±, NO, MDA levels and NF- Ã?Â?Ã?ºB expression associated to a decrease of GSH level in cerebral cortex and hippocampus after 15 days. The neuroinflammation is associated with seizure and cerebral alterations in cortex observed at 1 and 15 days and in the hippocampus only at 15 days. The use of an antioxidant prior to the KTX exerts a preventive effect not only on the neuroinflammatiion but also on altered tissues and the BBB disruption. This model could be a useful tool to study neuronal degeneration, as well as to better understand the mechanisms underlying neurodegenerative diseases and to improve and design new therapeutic strategies.
Subjects
ToxicologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Toxicology.
Perspective · 25 Feb 2026
Toxicological and Health Effects: Mechanisms, Exposure Routes and Prevention Strategies
Case report · 23 Feb 2026
Case Report: Methaemoglobinaemia Following Indoxacarb Ingestion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Toxicology
- SubjectToxicology
- BylineArticles whose byline prints “Fatima Laraba-Djebari”
- BylineArticles whose byline prints “Nesrine Sifi”
